Atezolizumab in Combination with Neoadjuvant Chemotherapy and Interval Cytoreductive Surgery for Patients with Newly-Diagnosed Advanced-Stage Epithelial Ovarian Cancer

Administered By

Awarded By

Contributors

Start/End

  • September 30, 2017 - December 31, 2022